Kozal Junior Syrup Mango is a pediatric formulation combining Levosalbutamol (0.5mg/5ml), Ambroxol (15mg/5ml), and Guaifenesin (50mg/5ml), designed to provide comprehensive relief from respiratory conditions characterized by bronchospasm, mucus hypersecretion, and cough. Levosalbutamol, a selective β2-adrenergic agonist, acts as a bronchodilator by relaxing the smooth muscles of the airways, thereby facilitating easier breathing in conditions such as asthma and bronchitis. Ambroxol serves as a mucolytic agent, promoting the breakdown and clearance of viscous mucus, enhancing mucociliary transport, and thereby aiding expectoration. Guaifenesin functions as an expectorant, increasing the volume and reducing the viscosity of bronchial secretions, which helps in clearing mucus from the respiratory tract. The syrup is formulated with a pleasant mango flavor to improve palatability and compliance in pediatric patients. Kozal Junior Syrup Mango is indicated for symptomatic relief in children suffering from acute and chronic respiratory tract disorders associated with productive cough and bronchospasm. It should be administered under medical supervision, with dosing adjusted according to the child’s age and clinical condition. Caution is advised in patients with hypersensitivity to any component, and it is contraindicated in cases of severe cardiac disorders or hyperthyroidism.